These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 34452321)

  • 1. Serological Cross-Reactions between Expressed VP2 Proteins from Different Bluetongue Virus Serotypes.
    Fay PC; Mohd Jaafar F; Batten C; Attoui H; Saunders K; Lomonossoff GP; Reid E; Horton D; Maan S; Haig D; Daly JM; Mertens PPC
    Viruses; 2021 Jul; 13(8):. PubMed ID: 34452321
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of antigenic epitopes of monoclonal antibodies against the VP2 protein of the 25 serotype of bluetongue virus.
    Xie S; Shi Y; Gong R; Cui W; Jiang Y; Liu M; Wang L; Zhou H; Qiao X; Li Y; Xu Y; Tang L
    Vet Microbiol; 2018 Jun; 219():136-143. PubMed ID: 29778186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of a Double-Antigen Microsphere Immunoassay for Simultaneous Group and Serotype Detection of Bluetongue Virus Antibodies.
    Breard E; Garnier A; Despres P; Blaise Boisseau S; Comtet L; Viarouge C; Bakkali-Kassimi L; Pourquier P; Hudelet P; Vitour D; Rossi S; Belbis G; Sailleau C; Zientara S
    Transbound Emerg Dis; 2017 Dec; 64(6):1837-1847. PubMed ID: 27667484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of bluetongue Disabled Infectious Single Animal (DISA) vaccine for different serotypes by VP2 exchange or incorporation of chimeric VP2.
    Feenstra F; Pap JS; van Rijn PA
    Vaccine; 2015 Feb; 33(6):812-8. PubMed ID: 25510389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implications of a conserved region of bluetongue virus protein VP2 in cross-neutralisation of bluetongue virus serotypes.
    Jyothi SJ; Patil SR; Reddy NY; Panduranga RP; Madala U; Prakash GM; Putty K
    Onderstepoort J Vet Res; 2020 Oct; 87(1):e1-e6. PubMed ID: 33054261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bluetongue virus outer-capsid protein VP2 expressed in
    Fay PC; Attoui H; Batten C; Mohd Jaafar F; Lomonossoff GP; Daly JM; Mertens PPC
    Vaccine X; 2019 Aug; 2():100026. PubMed ID: 31384743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serological differentiation of five bluetongue virus serotypes in indirect ELISA.
    Du Plessis DH
    Onderstepoort J Vet Res; 1992 Jun; 59(2):119-22. PubMed ID: 1325046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and differentiation of the twenty six bluetongue virus serotypes by RT-PCR amplification of the serotype-specific genome segment 2.
    Maan NS; Maan S; Belaganahalli MN; Ostlund EN; Johnson DJ; Nomikou K; Mertens PP
    PLoS One; 2012; 7(2):e32601. PubMed ID: 22389711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection.
    Stewart M; Dovas CI; Chatzinasiou E; Athmaram TN; Papanastassopoulou M; Papadopoulos O; Roy P
    Vaccine; 2012 Mar; 30(12):2131-9. PubMed ID: 22285887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. VP2-serotyped live-attenuated bluetongue virus without NS3/NS3a expression provides serotype-specific protection and enables DIVA.
    Feenstra F; Maris-Veldhuis M; Daus FJ; Tacken MG; Moormann RJ; van Gennip RG; van Rijn PA
    Vaccine; 2014 Dec; 32(52):7108-14. PubMed ID: 25454873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vesicular stomatitis virus replicon expressing the VP2 outer capsid protein of bluetongue virus serotype 8 induces complete protection of sheep against challenge infection.
    Kochinger S; Renevey N; Hofmann MA; Zimmer G
    Vet Res; 2014 Jun; 45(1):64. PubMed ID: 24928313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design of primers and use of RT-PCR assays for typing European bluetongue virus isolates: differentiation of field and vaccine strains.
    Mertens PPC; Maan NS; Prasad G; Samuel AR; Shaw AE; Potgieter AC; Anthony SJ; Maan S
    J Gen Virol; 2007 Oct; 88(Pt 10):2811-2823. PubMed ID: 17872535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of cross-protection of bluetongue virus serotype 4 with other serotypes in sheep.
    Zulu GB; Venter EH
    J S Afr Vet Assoc; 2014 Oct; 85(1):1041. PubMed ID: 25686101
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Complete genome characterisation of a novel 26th bluetongue virus serotype from Kuwait.
    Maan S; Maan NS; Nomikou K; Veronesi E; Bachanek-Bankowska K; Belaganahalli MN; Attoui H; Mertens PP
    PLoS One; 2011; 6(10):e26147. PubMed ID: 22031822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the immune response afforded by a subunit vaccine candidate against bluetongue virus in mice and sheep.
    Mohamed DKA; Du J; Gao S; Tian Z; Zhang G; Huang D; Du R; Kang B; Liu G; Luo J; Yin H
    Vet Microbiol; 2018 Jun; 219():40-48. PubMed ID: 29778203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Segment-2 sequence analysis and cross-neutralization studies on some Indian bluetongue viruses suggest isolates are VP2-variants of serotype 23.
    Tembhurne PA; Mondal B; Pathak KB; Biswas SK; Sanyal A; Yadav MP; Bandyopadhyay SK; Singh RK
    Arch Virol; 2010; 155(1):89-95. PubMed ID: 19936612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of VP7, a Bluetongue virus group specific antigen by viral vectors: analysis of the induced immune responses and evaluation of protective potential in sheep.
    Bouet-Cararo C; Contreras V; Caruso A; Top S; Szelechowski M; Bergeron C; Viarouge C; Desprat A; Relmy A; Guibert JM; Dubois E; Thiery R; Bréard E; Bertagnoli S; Richardson J; Foucras G; Meyer G; Schwartz-Cornil I; Zientara S; Klonjkowski B
    PLoS One; 2014; 9(11):e111605. PubMed ID: 25364822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-expression of VP2, NS1 and NS2-Nt proteins by an MVA viral vector induces complete protection against bluetongue virus.
    Jiménez-Cabello L; Utrilla-Trigo S; Calvo-Pinilla E; Lorenzo G; Illescas-Amo M; Benavides J; Moreno S; Marín-López A; Nogales A; Ortego J
    Front Immunol; 2024; 15():1440407. PubMed ID: 39072326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plant-produced Bluetongue chimaeric VLP vaccine candidates elicit serotype-specific immunity in sheep.
    Mokoena NB; Moetlhoa B; Rutkowska DA; Mamputha S; Dibakwane VS; Tsekoa TL; O'Kennedy MM
    Vaccine; 2019 Sep; 37(41):6068-6075. PubMed ID: 31471154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of an IGM-specific ELISA for early detection of bluetongue virus infections in domestic ruminants sera.
    Bréard E; Gorlier A; Viarouge C; Donnet F; Sailleau C; Schulz C; Hoffmann B; Comtet L; Beer M; Zientara S; Vitour D
    Transbound Emerg Dis; 2019 Jan; 66(1):537-545. PubMed ID: 30394662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.